DNA damage and innate immunity: Links and trade-offs

Trends in Immunology

Volumn 35, Issue 9, 2014, Pages 429-435

  Chatzinikolaou, Georgia ^a   Karakasilioti, Ismene ^a,b   Garinis, George A ^a,b  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

DNA damage; DNA repair; DNA sensors; Inflammation; Innate immunity

Indexed keywords

ADAPTIVE IMMUNITY; AGING; CHRONIC INFLAMMATION; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; EXCISION REPAIR; GENOME; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; MISMATCH REPAIR; MOLECULAR MECHANICS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION;

AGING; ANIMALS; DNA DAMAGE; DNA REPAIR; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION;

EID: 84922484139     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.06.003     Document Type: Review

References (89)

1. Brzostek-Racine S., et al. The DNA damage response induces IFN. J. Immunol. 2011, 187:5336-5345.
2. Zgur-Bertok D. DNA damage repair and bacterial pathogens. PLoS Pathog. 2013, 9:e1003711.
3. Babu M., et al. A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair. Mol. Microbiol. 2011, 79:484-502.
4. Kerur N., et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host Microbe 2011, 9:363-375.
5. Aglipay J.A., et al. A member of the pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene 2003, 22:8931-8938.
6. Frontini M., et al. A ChIP-chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response. Nucleic Acids Res. 2009, 37:1073-1085.
7. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
8. Stetson D.B., et al. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
9. Yang Y.G., et al. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 2007, 131:873-886.
10. Ishii K.J., et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 2006, 7:40-48.
11. Stetson D.B., Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006, 24:93-103.
12. Ablasser A., et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 2009, 10:1065-1072.
13. Chiu Y.H., et al. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138:576-591.
14. Sharma S., et al. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 2011, 35:194-207.
15. Paludan S.R., Bowie A.G. Immune sensing of DNA. Immunity 2013, 38:870-880.
16. Tang D., et al. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol. Rev. 2012, 249:158-175.
17. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
18. Lund J., et al. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 2003, 198:513-520.
19. Leifer C.A., et al. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 2004, 173:1179-1183.
20. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
21. Spies B., et al. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J. Immunol. 2003, 171:5908-5912.
22. Takaoka A., et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
23. Burckstummer T., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 2009, 10:266-272.
24. Fernandes-Alnemri T., et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
25. Hornung V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
26. Roberts T.L., et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009, 323:1057-1060.
27. Abe T., et al. STING recognition of cytoplasmic DNA instigates cellular defense. Mol. Cell 2013, 50:5-15.
28. Unterholzner L., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 2010, 11:997-1004.
29. Zhang Z., et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 2011, 12:959-965.
30. Sun L., et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
31. Wu J., et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013, 339:826-830.
32. Burdette D.L., et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011, 478:515-518.
33. Kawane K., et al. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 2003, 4:138-144.
34. Brooks P.J., et al. Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?. DNA Repair 2008, 7:834-848.
35. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993, 362:709-715.
36. Garinis G.A., Schumacher B. Transcription-blocking DNA damage in aging and longevity. Cell Cycle 2009, 8:2134-2135.
37. Garinis G.A., et al. Transcriptome analysis reveals cyclobutane pyrimidine dimers as a major source of UV-induced DNA breaks. EMBO J. 2005, 24:3952-3962.
38. Bennett C.B., et al. Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:5613-5617.
39. Kim H., D'Andrea A.D. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev. 2012, 26:1393-1408.
40. Grenon M., et al. Checkpoint activation in response to double-strand breaks requires the Mre11/Rad50/Xrs2 complex. Nat. Cell Biol. 2001, 3:844-847.
41. Masutani C., et al. Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J. 1994, 13:1831-1843.
42. Nishi R., et al. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein. Mol. Cell. Biol. 2005, 25:5664-5674.
43. Krokan H.E., Bjoras M. Base excision repair. Cold Spring Harb. Perspect. Biol. 2013, 5:a012583.
44. Pena-Diaz J., Jiricny J. Mammalian mismatch repair: error-free or error-prone?. Trends Biochem. Sci. 2012, 37:206-214.
45. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001, 15:2177-2196.
46. Shiloh Y., Kastan M.B. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 2001, 83:209-254.
47. Matsuoka S., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
48. Kamileri I., et al. Nucleotide excision repair: new tricks with old bricks. Trends Genet. 2012, 28:566-573.
49. Price B.D., D'Andrea A.D. Chromatin remodeling at DNA double-strand breaks. Cell 2013, 152:1344-1354.
50. Chiruvella K.K., et al. Repair of double-strand breaks by end joining. Cold Spring Harb. Perspect. Biol. 2013, 5:a012757.
51. Skalka A.M., Katz R.A. Retroviral DNA integration and the DNA damage response. Cell Death Differ. 2005, 12(Suppl. 1):971-978.
52. Daniel R., et al. Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway. J. Virol. 2004, 78:8573-8581.
53. Daniel R., et al. Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4778-4783.
54. Stracker T.H., et al. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 2002, 418:348-352.
55. Zhang X., et al. Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J. Immunol. 2011, 186:4541-4545.
56. Ferguson B.J., et al. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife 2012, 1:e00047.
57. Kondo T., et al. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:2969-2974.
58. Roth S., et al. Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1beta production. Nat. Immunol. 2014, 15:538-545.
59. Weiner A.M., Gray L.T. What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome?. Mech. Ageing Dev. 2013, 134:225-233.
60. Crow Y.J., Livingston J.H. Aicardi-Goutières syndrome: an important Mendelian mimic of congenital infection. Dev. Med. Child Neurol. 2008, 50:410-416.
61. Crow Y.J. Type I interferonopathies: a novel set of inborn errors of immunity. Ann. N. Y. Acad. Sci. 2011, 1238:91-98.
62. Liu Z.G., et al. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 1996, 384:273-276.
63. Gonzalez S., et al. NKG2D ligands: key targets of the immune response. Trends Immunol. 2008, 29:397-403.
64. Gorgoulis V.G., et al. p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner. EMBO J. 2003, 22:1567-1578.
65. Huang T.T., et al. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003, 115:565-576.
66. Li N., et al. ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J. Biol. Chem. 2001, 276:8898-8903.
67. Pamment J., et al. Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. Oncogene 2002, 21:7776-7785.
68. Hinz M., et al. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-kappaB activation. Mol. Cell 2010, 40:63-74.
69. Karakasilioti I., et al. DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria. Cell Metab. 2013, 18:403-415.
70. Cerboni C., et al. The DNA damage response: a common pathway in the regulation of NKG2D and DNAM-1 ligand expression in normal, infected, and cancer cells. Front. Immunol. 2014, 4:508.
71. Smyth M.J., et al. NKG2D function protects the host from tumor initiation. J. Exp. Med. 2005, 202:583-588.
72. Lopez-Larrea C., et al. The NKG2D receptor: sensing stressed cells. Trends Mol. Med. 2008, 14:179-189.
73. Champsaur M., Lanier L.L. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 2010, 235:267-285.
74. Gasser S., et al. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436:1186-1190.
75. Gasser S., Raulet D.H. The DNA damage response arouses the immune system. Cancer Res. 2006, 66:3959-3962.
76. Himmelreich H., et al. Post-transcriptional regulation of ULBP1 ligand for the activating immunoreceptor NKG2D involves 3' untranslated region. Hum. Immunol. 2011, 72:470-478.
77. Shibuya A., et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996, 4:573-581.
78. Soriani A., et al. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 2009, 113:3503-3511.
79. Bottino C., et al. Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 2003, 198:557-567.
80. Tang M.L., et al. The DNA damage response induces antigen presenting cell-like functions in fibroblasts. Eur. J. Immunol. 2013, 44:1108-1118.
81. Garinis G.A., et al. DNA damage and ageing: new-age ideas for an age-old problem. Nat. Cell Biol. 2008, 10:1241-1247.
82. Coppe J.P., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008, 6:2853-2868.
83. Bruunsgaard H., et al. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 2001, 8:131-136.
84. Freund A., et al. p38 MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 2011, 30:1536-1548.
85. Rodier F., et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 2009, 11:973-979.
86. Grivennikov S.I., et al. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
87. Tilstra J.S., et al. NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J. Clin. Invest. 2012, 122:2601-2612.
88. Roberts T.L., et al. Smg1 haploinsufficiency predisposes to tumor formation and inflammation. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E285-E294.
89. Ermolaeva M.A., et al. DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance. Nature 2013, 501:416-420.